|
|
Biotech
|
|
||
Blackstone doing some innovating investing in biotech...can't quite tell if this will push more money into biotech stocks or take money out due to alternative investing approaches using venture cap to invest in private companies. Read somewhere that venture cap money is funding so many early-stage biotechs that it is limiting number of publicly traded companies available to investors. Venture cap funding can take a company through Phase1 trial or later before a startup goes public for more financing. |
return to message board, top of board |